Inozyme Pharma shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Inozyme Pharma by MPM Oncology Impact Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $1.4M | 327k | 4.20 |
2023-06-30 | $1.8M | 327k | 5.57 |
2023-03-31 | $1.3M | 234k | 5.73 |
2022-12-31 | $242k | 231k | 1.05 |
2022-09-30 | $1.8M | 661k | 2.68 |
2022-06-30 | $3.2M | 665k | 4.77 |
2022-03-31 | $1.2M | 295k | 4.09 |
2021-12-31 | $2.1M | 303k | 6.82 |
2021-09-30 | $3.7M | 321k | 11.59 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management